The invention relates to a composition for use in treating corneal and conjunctival lesions, wherein the composition comprises a prostaglandin F2alpha or analogue, in a therapeutic amount, said composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative； the invention also relates to a method for treating surface ocular conditions in a patient in need thereof, comprising administering a composition of the invention.
